Loading clinical trials...

Motivational Interviewing for Stroke | Clinical Trials | Clareo Health

TERMINATEDNA

Motivational Interviewing for Stroke

Motivational Interviewing to Improve Outcomes After Stroke or Transient Ischemic Attack Attributable to Tobacco Use

NCT06195007•University of Florida

Summary

Motivational interviewing (MI) is a style of communication designed to elicit a person's own reasons for change to drive commitment toward a goal. The goal of this study is to assess the effect of trainee-led MI on patients diagnosed with acute stroke or TIA attributable to modifiable risk factors in comparison to conventional post-stroke counseling, based on patient outcomes, and meaning of work and sense of fulfillment for trainees.

Eligibility

Age

18 - 99 years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•Patient presentation consistent with a stroke or TIA
•Patient is a current tobacco user and tobacco use contributed to the stroke
•Resident enrolled in study assigned to Vascular Neurology service during patient admission.

Exclusion Criteria

•Patient unable or unwilling to follow up in the outpatient stroke clinic after discharge
•Patient has cognitive impairment or aphasia that would preclude meaningful participation in motivational interview (defined as a score of 0 on the National Institute of Health Stroke Scale \[NIHSS\] questions 1 and 9)

Locations (1)

University of Florida

Gainesville, Florida, United States

Key Dates

Start Date

December 20, 2023

Primary Completion Date

December 20, 2023

Completion Date

January 1, 2024

Last Updated

August 21, 2024

Enrollment

ACTUAL participants

Conditions

Acute StrokeTransient Ischemic Attack

Interventions

Motivational Interview

BEHAVIORAL

Effects of tES Combined With CMDT Gait Training on Cognition, Cortical Activity, Spinal Motoneuron Excitability and Motor Performance in Stroke Individuals

NCT07236216

Hemorrhagic StrokeIschemic Stroke+2 more

View study

RECRUITINGNA

Secondary Prevention of Ischemic Stroke and Transient Ischemic Attack With an Intelligent Management System

NCT06783049

Ischemic StrokeTransient Ischemic Attack (TIA)

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: August 21, 2024Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Motivational Interviewing for Stroke

Inclusion Criteria

Exclusion Criteria

Effects of tES Combined With CMDT Gait Training on Cognition, Cortical Activity, Spinal Motoneuron Excitability and Motor Performance in Stroke Individuals

Secondary Prevention of Ischemic Stroke and Transient Ischemic Attack With an Intelligent Management System

Effect of the Intelligent Lipid Management Decision-support System on 1-year LDL-C Target Achievement in Ischemic Stroke or TIA Patients Under Evolocumab Treatment in China

Mirror Therapy for Hand Function Recovery in Acute Stroke

Radiofrequency and Cryoablation of the Posterior Wall of the Left Atrium

Integrated Approach in Frail Older People with Atrial Fibrillation